Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine

Pharmacology Biochemistry and Behavior

Volumn 76, Issue 3-4, 2003, Pages 525-533

  El Sherbiny, Doaa A ^a   Khalifa, Amani E ^a,c   Attia, Amina S ^b   Eldenshary, Ezz El Din S ^b  

^a Ain Shams University   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c NONE   (Egypt)

Author keywords

Antioxidant; Dementia; Hypericum; Rat; Scopolamine

Indexed keywords

ANTIOXIDANT; FLAVONOID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; MALONALDEHYDE; PLANT EXTRACT; SCOPOLAMINE; SUPEROXIDE DISMUTASE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; BRAIN DYSFUNCTION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FEAR; HYPERICUM PERFORATUM; LEARNING; MALE; MEDICAL DOCUMENTATION; MEDICINAL PLANT; MEMORY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALIA; HYPERICUM; HYPERICUM PERFORATUM;

EID: 0345708155     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2003.09.014     Document Type: Article

References (63)

1. Abd El-Gawad H.M., Khalifa A.E. Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain. Pharmacol. Res. 43:2001;257-263.
2. Balazs L., Leon M. Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 19:1994;1131-1137.
3. Barnes J., Anderson L.A., Phillipson J.D. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J. Pharm. Pharmacol. 53:2001;583-600.
4. Bassett C.N., Montine T.J. Lipoproteins and lipid peroxidation in Alzheimer's disease. J. Nutr. Health Aging. 7:2003;446-451.
5. Bassuk S.S., Berkman L.F., Wypij D. Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch. Gen. Psychiatry. 55:1998;1073-1081.
6. Bejar C., Wang R., Weinstock M. Effect of rivastigmine on scopolamine-induced memory impairment in rats. Eur. J. Pharmacol. 383:1999;231-240.
7. Bharath S., Hsu M., Kaur D., Rajagopalan S., Andersen J.K. Glutathione, iron and Parkinson's disease. Biochem. Pharmacol. 64:2002;1037-1048.
8. Bladt S., Wagner H. Inhibition of MAO by fractions and constituents of hypericum extract. J. Geriatr. Psychiatry Neurol. 7:1994;S57-S59.
9. Chatterjee S.S., Noldner M., Koch E., Erdelmeier C. Antidepressant activity of Hypericum perforatum and hyperforin: the neglected possibility. Pharmacopsychiatry. 31:1998;7-15.
10. Chen L., Richardson J.S., Caldwell J.E., Ang L.C. Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls. Int. J. Neurosci. 75:1994;83-90.
11. Clausen J. Demential syndromes and the lipid metabolism. Acta Neurol. Scand. 70:1984;345-355.
12. Cruz R., Almaguer Melian W., Bergado Rosado J.A. Glutathione in cognitive function and neurodegeneration. Rev. Neurol. 36:2003;877-886.
13. Cruz-Aguado R., Fernandez-Verdecia C.I., Diaz-Suarez C.M., Gonzalez-Monzon O., Antunez-Potashkina I., Bergado-Rosado J. Effects of nerve growth factor on brain glutathione-related enzymes from aged rats. Fundam. Clin. Pharmacol. 12:1998;538-545.
14. de Angelis L., Furlan C. The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice. Neurobiol. Learn. Mem. 64:1995;119-124.
15. Di Carlo G., Borrelli F., Izzo A.A., Ernst E. St. John's wort: Prozac from the plant kingdom. Trends Pharmacol. Sci. 22:2001;292-297.
16. Dringen R., Hirrlinger J. Glutathione pathways in the brain. Biol. Chem. 384:2003;505-516.
17. Ellman G.L. Tissue sulfhydryl group. Arch. Biochem. Biophys. 74:1959;214-226.
18. Floyd R.A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 222:1999;236-245.
19. Gallassi R., Morreale A., Pagni P. The relationship between depression and cognition. Arch. Gerontol. Geriatr. 33:2001;163-171.
20. Gu M., Owen A.D., Toffa S.E., Cooper J.M., Dexter D.T., Jenner P.et al. Mitochondrial function, GSH, and iron in neurodegeneration and Lewy body diseases. J. Neurol. Sci. 158:1998;24-29.
21. Gulyaeva N.V., Lazareva N.A., Libe M.L., Mitrokhina O.S., Onufriev M.V., Stepanichev M.Yu.et al. Oxidative stress in the brain following intraventricular administration of ethylcholine aziridinium (AF64A). Brain Res. 726:1996;174-180.
22. Hashimoto M., Hashimoto T., Kuriyama K. Protective effect of WEB 1881 FU on AF64A (ethylcholine aziridinium ion)-induced impairment of hippocampal cholinergic neurons and learning acquisition. Eur. J. Pharmacol. 209:1991;9-14.
23. Heilmann J., Winkelmann K., Sticher O. Studies on the antioxidative activity of phloroglucinol derivatives isolated from hypericum species. Planta Med. 69:2003;202-206.
24. Hiramatsu M., Murasawa H., Mori H., Kameyama T. Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous k-opioid receptor agonist. Br. J. Pharmacol. 123:1998;920-926.
25. Hiramatsu M., Murasawa H., Nabeshima T., Kameyama T. Effects of U-50, 488H on scopolamine-, mecamylamine-, and dizoclipine-induced learning and memory impairment in rats. J. Pharmacol. Exp. Ther. 284:1998;858-867.
26. Howes M.J., Houghton P.J. Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol. Biochem. Behav. 75:2003;513-527.
27. Hunt E.J., Lester C.E., Lester E.A., Tackett R.L. Effect of St. John's wort on free radical production. Life Sci. 69:2001;181-190.
28. Ilic T.V., Jovanovic M., Jovicic A., Tomovic M. Oxidative stress indicators are elevated in de novo Parkinson's disease patients. Funct. Neurol. 14:1999;141-147.
29. Ishige K., Schubert D., Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med. 30:2001;433-446.
30. Kasper S. Hypericum perforatum: a review of clinical studies. Pharmacopsychiatry. 34:2001;51-55.
31. Khalifa A.E. Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of passive avoidance conditioning in mice. J. Ethnopharmacol. 76:2001;49-57.
32. Kish S.J., Morito C.L., Hornykiewicz O. Brain glutathione peroxidase in neurodegenerative disorders. Neurochem. Pathol. 4:1986;23-28.
33. Klusa V., Germane S., Noldner M., Chatterjee S.S. Hypericum extract and hyperforin: memory-enhancing properties in rodents. Pharmacopsychiatry. 34:2001;61-69.
34. Kumar M.H., Gupta Y.K. Antioxidant property of Celastrus paniculatus Willd.: a possible mechanism in enhancing cognition. Phytomedicine. 9:2002;302-311.
35. Kumar V., Singh P., Muruganandam A.V., Bhattacharya S.K. Effect of Indian Hypericum perforatum Linn on animal models of cognitive dysfunction. J. Ethnopharmacol. 72:2000;119-128.
36. Kvaltinova Z., Juranek I., Machova J., Stolc S. Effect of oxidative stress on (3H)-N-methylscopolamine binding and production of thiobarbituric acid reactive substances in rat cerebral cortex membranes. Gen. Physiol. Biophys. 12:1993;155-161.
37. Maidment I. The use of St John's wort in the treatment of depression. Psychiatr. Bull. 24:2000;232-234.
38. Maier C.M., Chan P.H. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist. 8:2002;323-334.
39. Marcus D.L., Thomas C., Rodriguez C., Simberkoff K., Tsai J.S., Strafaci J.A.et al. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150:1998;40-44.
40. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47:1974;469-474.
41. Misane I., Ogren S.O. Selective 5-HT(1A) antagonists WAY 100635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat. Neuropsychopharmacology. 28:2003;253-264.
42. Mishima K., Tsukikawa H., Miura I., Inada K., Abe K., Matsumoto Y.et al. Ameliorative effect of NC-1900, a new AVP(4-9) analog, through vasopressin V(1A) receptor on scopolamine-induced impairments of spatial memory in the eight-arm radial maze. Neuropharmacology. 44:2003;541-552.
43. Naarala J., Tervo P., Loikkanen J., Savolainen K. Cholinergic-induced production of reactive oxygen species in human neuroblastoma cells. Life Sci. 60:1997;1905-1914.
44. Ohno M., Watanabe S. Interactive processing between glutamatergic and cholinergic systems involved in inhibitory avoidance learning of rats. Eur. J. Pharmacol. 312:1996;145-147.
45. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70:1967;158-169.
46. Palmer A.M. The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. J. Neural. Transm. 106:1999;317-328.
47. Palsson S., Aevarsson O., Skoog I. Depression, cerebral atrophy, cognitive performance and incidence of dementia - population study of 85-year-olds. Br. J. Psychiatry. 174:1999;249-253.
48. Ramassamy C., Averill D., Beffert U., Theroux L., Lussier-Cacan S., Cohn J.S.et al. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol. Dis. 7:2000;23-37.
49. Rivas-Arancibia S., Dorado-Martinez C., Borgonio-Perez G., Hiriart-Urdanivia M., Verdugo-Diaz L., Duran-Vazquez A.et al. Effects of taurine on ozone-induced memory deficits and lipid peroxidation levels in brains of young, mature, and old rats. Environ. Res. 82:2000;7-17.
50. Rosenzweig P., Patat A., Zieleniuk I., Cimarosti I., Allain H., Gandon J.M. Cognitive performance in elderly subjects after a single dose of befloxatone, a new reversible selective monoamine oxidase A inhibitor. Clin. Pharmacol. Ther. 64:1998;211-222.
51. Rubaj A., Zgodzinski W., Sieklucka-Dziuba M. The influence of adenosine A3 receptor agonist: IB-MECA, on scopolamine- and MK-801-induced memory impairment. Behav. Brain Res. 141:2003;11-17.
52. Saija A., Scalese M., Lanza M., Marzullo D., Bonina F., Castelli F. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic. Biol. Med. 19:1995;481-486.
53. Savolainen K., Hirvonen M.R., Naarala J. Phosphoinositide second messengers in cholinergic excitotoxicity. Neurotoxicology. 15:1994;493-502.
54. Sharma M., Gupta Y.K. Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacol. Biochem. Behav. 70:2001;325-331.
55. Singh A., Naidu P.S., Gupta S., Kulkarni S.K. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J. Med. Food. 5:2002;211-220.
56. Sloley B.D., Urichuk L.J. Chemical and pharmacological evaluation of Hypericum perforatum extracts. Acta Pharmacol. Sin. 21:2000;1145-1152.
57. Uchiyama M., Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86:1978;271-278.
58. Veerendra Kumar M.H., Gupta Y.K. Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats. Pharmacol. Biochem. Behav. 73:2002;565-571.
59. Vitiello B. Hypericum perforatum extracts as potential antidepressants. J. Pharm. Pharmacol. 51:1999;513-517.
60. Wanibuchi F., Nishida T., Yamashita H., Hidaka K., Koshiya K., Tsukamoto S.et al. Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in-vivo pharmacological studies. Eur. J. Pharmacol. 265:1994;151-158.
61. Wilson J.X. Antioxidant defense of the brain: a role for astrocytes. Can. J. Physiol. Pharmacol. 75:1997;1149-1163.
62. Wright J.W., Clemens J.A., Panetta J.A., Smalstig E.B., Weatherly L.A., Kramar E.A.et al. Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats. Brain Res. 717:1996;1-11.
63. Zimakov Lu.A., Gukasov V.M., KaplanZimakov I.E. Effect of acetylcholine, cholinomimetics, cholinolytics and dipiroxim on the chemiluminescence of a model system of peroxidation. Farmakol. Toksikol. 46:1983;20-23.